The CYP26B1 gene helps control levels of retinoic acid, a form of vitamin A that guides early growth of bones, the face, and other tissues. When this gene does not work properly, retinoic acid can build up and interfere with normal development before birth. This gene plays an important role in shaping the skeleton, so pathogenic variants can cause a rare condition with short or bowed limbs, joint problems, and changes in the skull or face. The CYP26B1 gene is mainly known in rare disease genetics rather than in popular culture.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or guiding processes throughout the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
CYP26B1Gene function
What if the gene works
The CYP26B1 gene helps break down retinoic acid, a form of vitamin A that guides growth signals. This helps keep vitamin A signaling balanced during early development, especially in bones, joints, and other tissues.
Risk
What if the gene does not work
Variants in the CYP26B1 gene can disrupt vitamin A signal balance during development, causing bone growth conditions that range from early fusion of skull bones to severe skeletal differences before or soon after birth.
Treatment
What does that mean for your treatment
No CYP26B1-specific treatment or drug choice is currently established for pathogenic variants in the CYP26B1 gene. Researchers are studying the CYP26B1 gene in retinoic acid signaling to see whether it may serve as a biomarker or drug target in some cancers and developmental conditions.
Conditions associated with CYP26B1
Gene function
What if the gene works
Your cells need careful control of vitamin A signals as tissues grow and take shape. The CYP26B1 gene helps keep those signals in the right range by breaking down retinoic acid, the active form of vitamin A. This is especially important during early development and normal bone growth.
Its protein breaks down retinoic acid after it has delivered its message. This keeps active vitamin A signals from building up more than your cells need.
By adjusting how much retinoic acid remains in a tissue, this gene helps cells receive the right strength of signal. That steady control is a core part of how the CYP26B1 gene supports growth and development.
Careful retinoic acid control helps tissues grow in the right place and at the right time. This supports normal patterning of developing bones, joints, and nearby structures.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many CYP26B1 gene variants weaken the enzyme, so cells break down retinoic acid less effectively and signaling during early development becomes harder to control. In descriptions of how CYP26B1 gene variants affect protein function, milder variants may leave some enzyme activity, while more severe variants can markedly reduce stability, folding, or activity. This range often helps explain why associated skeletal and craniofacial features may vary in timing and severity.
How variants are linked to conditions
In published studies, CYP26B1 gene variants and skeletal abnormalities are closely linked, especially when both copies of the CYP26B1 gene carry a pathogenic variant. This can cause a rare inherited condition with changes in bone growth involving the skull, face, spine, and limbs. Some people also have fused joints and hearing or vision differences, and the severity can vary.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not directly affect health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well understood variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risk related to CYP26B1. For known CYP26B1-related conditions, risk is mainly linked to the genetic change itself and whether it runs in a family.
Inheritance of CYP26B1 variants
For families looking into how CYP26B1 gene variants are inherited, the best-established pattern is autosomal recessive. This means a child usually inherits one CYP26B1 gene variant from each parent, and both parents are typically healthy carriers. When both parents carry the same CYP26B1 gene variant, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant pair.
What does my CYP26B1 result mean for my family?
For CYP26B1-related conditions, family impact is usually discussed in a recessive pattern. This often means parents can carry the gene change without having symptoms, while brothers or sisters may also have the condition or be carriers. Children of someone with a CYP26B1-related condition will usually be carriers, and the chance of a child being affected depends on whether the other parent also carries a CYP26B1 change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CYP26B1 variants usually uses a blood sample or cheek swab. A lab reads the DNA code in the CYP26B1 gene to look for changes linked to the condition being assessed, and the result may show a disease-causing variant, no relevant variant, or a finding that needs expert interpretation.
When should I consider getting a genetic test?
Genetic testing for the CYP26B1 gene may be worth considering when a baby or child has unusual bone or skull growth, such as skull bones joining too early, major limb differences, or a similar pattern seen in close relatives. It can help confirm whether CYP26B1 is involved and clarify the chance of it happening again in a future pregnancy.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it explains varies by the condition and the type of variant. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, moves, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics explores how genetic differences can affect a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the CYP26B1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
Research on the CYP26B1 gene took shape in the early 2000s as scientists studied how embryos control exposure to vitamin A related signals during development. From these first observations, research expanded steadily. Animal studies helped show that this gene was important for shaping the skeleton, limbs, and other tissues at the right time. Later, doctors linked rare variants in the CYP26B1 gene to inherited conditions affecting bone growth and joint formation in some children. Over time, these findings made CYP26B1 part of the broader story of how genes guide early human development.